1. Home
  2. MMYT vs EXAS Comparison

MMYT vs EXAS Comparison

Compare MMYT & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MMYT
  • EXAS
  • Stock Information
  • Founded
  • MMYT 2000
  • EXAS 1995
  • Country
  • MMYT India
  • EXAS United States
  • Employees
  • MMYT N/A
  • EXAS N/A
  • Industry
  • MMYT Transportation Services
  • EXAS Medical Specialities
  • Sector
  • MMYT Consumer Discretionary
  • EXAS Health Care
  • Exchange
  • MMYT Nasdaq
  • EXAS Nasdaq
  • Market Cap
  • MMYT 11.6B
  • EXAS 10.5B
  • IPO Year
  • MMYT 2010
  • EXAS N/A
  • Fundamental
  • Price
  • MMYT $101.74
  • EXAS $53.74
  • Analyst Decision
  • MMYT Strong Buy
  • EXAS Strong Buy
  • Analyst Count
  • MMYT 3
  • EXAS 16
  • Target Price
  • MMYT $101.67
  • EXAS $72.80
  • AVG Volume (30 Days)
  • MMYT 445.4K
  • EXAS 2.2M
  • Earning Date
  • MMYT 01-23-2025
  • EXAS 02-19-2025
  • Dividend Yield
  • MMYT N/A
  • EXAS N/A
  • EPS Growth
  • MMYT 689.76
  • EXAS N/A
  • EPS
  • MMYT 1.88
  • EXAS N/A
  • Revenue
  • MMYT $882,615,000.00
  • EXAS $2,692,328,000.00
  • Revenue This Year
  • MMYT $29.20
  • EXAS $11.81
  • Revenue Next Year
  • MMYT $20.87
  • EXAS $11.52
  • P/E Ratio
  • MMYT $56.76
  • EXAS N/A
  • Revenue Growth
  • MMYT 28.95
  • EXAS 11.91
  • 52 Week Low
  • MMYT $47.04
  • EXAS $40.62
  • 52 Week High
  • MMYT $123.00
  • EXAS $79.62
  • Technical
  • Relative Strength Index (RSI)
  • MMYT 38.12
  • EXAS 42.11
  • Support Level
  • MMYT $98.41
  • EXAS $49.79
  • Resistance Level
  • MMYT $109.19
  • EXAS $54.86
  • Average True Range (ATR)
  • MMYT 4.85
  • EXAS 2.73
  • MACD
  • MMYT -1.33
  • EXAS -0.31
  • Stochastic Oscillator
  • MMYT 15.80
  • EXAS 34.63

About MMYT MakeMyTrip Limited

MakeMyTrip Ltd is an online travel company, which provides online booking solutions for day-to-day travel needs. The company's operating segment includes Air ticketing; Hotels and packages; Bus ticketing and Others. It generates maximum revenue from the Hotels and packages segment. The Hotels and packages segments include internet-based platforms, call-centers, and branch offices, which provide holiday packages and hotel reservations. Its Air ticketing segment includes internet-based platforms, provides the facility to book domestic and international air tickets. Geographically, it derives a majority of revenue from India and also has a presence in the United States; South East Asia; Europe, and other countries.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: